Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Squamous NSCLC, EGFR Targeting

Nick Thatcher

PhD, FRCP

🏢The Christie NHS Foundation Trust🌐UK

Emeritus Professor of Medical Oncology

62
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Professor Nick Thatcher is an eminent British thoracic oncologist who was a principal investigator in the SQUIRE trial evaluating necitumumab (an anti-EGFR antibody) in combination with gemcitabine-cisplatin for first-line squamous NSCLC. He has contributed to numerous landmark lung cancer trials across his career and has been a leading voice in European thoracic oncology clinical research.

Share:

🧪Research Fields 研究领域

necitumumab squamous NSCLC
SQUIRE trial necitumumab gemcitabine cisplatin
EGFR antibody squamous
British thoracic oncology
lung cancer systemic therapy

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Nick Thatcher 的研究动态

Follow Nick Thatcher's research updates

留下邮箱,当我们发布与 Nick Thatcher(The Christie NHS Foundation Trust)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment